Participating Faculty: Evaluating the Role of Incretin-Based Therapies in the Management of Type 2 DiabetesByApril 1st 2011
Liraglutide: A Review of the First Once-Daily GLP-1 Receptor AgonistByBruce Bode, MD, FACEMarch 23rd 2011
Differentiating Incretin-Based Therapies for Population-Based Health CareByDavid Calabrese, RPh, MHPMarch 23rd 2011
Application of Comparative Effectiveness Research in Evaluation of Treatments for Type 2 Diabetes MellitusByAndrew Ahmann, MDMarch 23rd 2011
Introduction: Evaluating the Role of Incretin-Based Therapies in the Management of Type 2 DiabetesByMarch 23rd 2011
